Funding
The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2024Preclinical Testing of Novel DBS Protocol for Long-Lasting Therapeutic Effects
Study Rationale: Deep brain stimulation is an effective therapy for motor symptoms of late-stage Parkinson’s disease. It works like a pacemaker to interrupt abnormal patterns of brain activity that...
-
Research Grant, 2024Developing Outcome Measures for Assessing Freezing of Gait: A Multi-Center Study
Study Rationale: Standardized and accurate assessment of freezing of gait (FOG), a debilitating symptom of Parkinson’s disease (PD), is needed to develop and rigorously test novel therapies. However...
-
Therapeutic Pipeline Program, 2024Photoreceptor-directed Light Therapy in Parkinson’s Disease
Study Rationale: Non-motor symptoms including sleep disturbances are common and enormously impact on the quality of life in people with Parkinson’s disease. Sleep disruption affects motor function and...
-
Edmond J. Safra Movement Disorders Research Career Development Award, 2024Towards a Better Understanding of Treatment-refractory Gait Issues in Parkinson’s Disease
Study Rationale: Freezing of gait (FOG) is a sudden arrest of gait despite the intention to continue walking, often while a person is turning, walking in a confined space or is in a situation that...
-
Research Grant, 2024Developing an Open-access Repository of High-quality Digital Measurement Tools for Use in Parkinson’s Disease Research and Care
Study Rationale: This study will bring together leaders in Parkinson’s disease (PD) and digital health innovation and measurement to develop and maintain an open-access repository of high-quality...
-
2022: Accelerated Therapeutics Program, 2024(SUPPLEMENT) Small Molecule Mitochondrial Modulators for the Treatment of Parkinson's Disease
Study Rationale: Mitochondrial dysfunction is a crucial driver of the initiation and progression of Parkinson’s disease (PD). Mitochondria are structures that produce cellular energy, and in neurons...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.